Education
About Us
Working with TipRanks
Follow Us
GINN - ETF AI Analysis
Top Page
Goldman Sachs ETF Trust Goldman Sachs Innovate Equity ETF (GINN)
Rating:69Neutral
Price Target:―
Positive Factors
Recognizable Innovative Leaders
The ETF holds many well-known technology and growth companies, which have historically driven much of the market’s innovation and long-term growth.
Global Diversification with U.S. Core
While most assets are in U.S. stocks, the fund also includes meaningful exposure to other major markets like Hong Kong, Japan, and Europe, helping spread country-specific risk.
Balanced Sector Mix in Growth Areas
Large weights in technology and health care, along with exposure to consumer and financial sectors, give investors a mix of growth-focused industries rather than a single-sector bet.
Negative Factors
Heavy Tilt Toward U.S. Market
With the majority of holdings in U.S. companies, the fund’s returns are highly tied to how the U.S. market performs, offering less benefit if other regions do better.
Weakness in Several Top Tech Names
Some of the largest technology holdings have shown weak recent performance, which can drag on the fund given their meaningful weights in the portfolio.
Moderate Expense Ratio
The fund’s fee is higher than many broad market index ETFs, which slightly reduces the net return investors keep over time.
GINN vs. SPDR S&P 500 ETF (SPY)
AUM213.00M
RegionGlobal
Expense Ratio0.50%
Beta1.10
IssuerGoldman Sachs
Inception DateNov 06, 2020
Dividend Yield1.27%
Asset ClassEquity
Index TrackedSolactive Innovative Global Equity Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume7,404
30 Day Avg. Volume7,694
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
90.82Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering464
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GINN Summary
The Goldman Sachs Innovate Equity ETF (GINN) tracks the Solactive Innovative Global Equity Index and focuses on companies driving new ideas in technology, healthcare, and other forward-looking industries. It holds many well-known names such as Apple, Microsoft, Amazon, and Nvidia, with most of its investments in U.S. companies. Someone might consider this ETF if they want broad exposure to innovative businesses around the world in a single, diversified fund with growth potential. A key risk is that it is heavily tilted toward tech and innovation stocks, which can be more volatile and can go up and down sharply with the market.
How much will it cost me?The Goldman Sachs Innovate Equity ETF (GINN) has an expense ratio of 0.50%, which means you’ll pay $5 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to focus on innovative companies across multiple sectors. The higher cost reflects the specialized strategy and research involved in selecting these forward-thinking investments.
What would affect this ETF?The Goldman Sachs Innovate Equity ETF (GINN) could benefit from continued advancements in technology, healthcare, and renewable energy, as these sectors are key drivers of global innovation and are heavily represented in its portfolio. However, the ETF may face challenges from rising interest rates, which can negatively impact growth-oriented companies, and regulatory changes in major markets like the U.S. and China, where many of its top holdings operate. Global economic conditions and geopolitical tensions could also influence the performance of this ETF, given its broad geographic exposure.
GINN Top 10 Holdings
GINN’s story is still all about big, global innovators, with U.S. tech and internet giants setting the tone. Alphabet and Amazon have been quietly rising, helping to pull the fund forward, while Intel’s sharp rebound has become an unexpected engine of momentum. On the flip side, Apple, Microsoft, Meta, and Tesla are losing steam, acting more like brakes than boosters lately. Tencent adds a touch of China exposure but has been mixed, and Eli Lilly’s strong run underscores the fund’s tilt toward cutting‑edge healthcare alongside Big Tech.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Alphabet Class A | 2.41% | $5.14M | $4.02T | 64.60% | 85 Outperform | |
| Apple | 1.99% | $4.23M | $4.06T | 18.94% | 79 Outperform | |
| Amazon | 1.93% | $4.12M | $2.49T | -1.35% | 71 Outperform | |
| Nvidia | 1.90% | $4.04M | $4.23T | 51.99% | 76 Outperform | |
| Meta Platforms | 1.84% | $3.91M | $1.69T | -1.77% | 76 Outperform | |
| Microsoft | 1.64% | $3.49M | $3.08T | -0.28% | 79 Outperform | |
| Tencent Holdings | 1.26% | $2.69M | HK$5.04T | 34.42% | 75 Outperform | |
| Intel | 1.22% | $2.60M | $242.76B | 155.31% | 64 Neutral | |
| Tesla | 1.08% | $2.29M | $1.52T | 7.58% | 73 Outperform | |
| Alibaba Group Holding Ltd. | 0.97% | $2.06M | HK$2.68T | 63.50% | 70 Outperform |
GINN Technical Analysis
Negative
―
Price Trends
74.11
Negative
73.69
Negative
69.43
Positive
Market Momentum
-0.12
Positive
35.70
Neutral
15.86
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GINN, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 75.13, equal to the 50-day MA of 74.11, and equal to the 200-day MA of 69.43, indicating a neutral trend. The MACD of -0.12 indicates Positive momentum. The RSI at 35.70 is Neutral, neither overbought nor oversold. The STOCH value of 15.86 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GINN.
GINN Peer Comparison
Comparison Results
Performance Comparison
GINN
Goldman Sachs ETF Trust Goldman Sachs Innovate Equity ETF
72.65
8.59
13.41%
BUG
Global X Cybersecurity Etf
―
―
―
ILDR
First Trust Innovation Leaders ETF
―
―
―
TMAT
Main Thematic Innovation ETF
―
―
―
SPRX
Spear Alpha ETF
―
―
―
TPZ
Tortoise Essential Energy Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents